Introduction
The adenomatous polyposis coli (APC) tumour suppressor gene encodes the adenomatous polyposis coli protein. Individuals with germ line inactivating mutations of this gene are predisposed to develop hundreds to thousands of adenomatous polyps in the colon and rectum, the hallmark of the hereditary cancer syndrome familial adenomatous polyposis (FAP) (1) . Moreover, the majority of sporadic colorectal tumours is initiated by mutations in APC (2,3). The APC protein has a broad spectrum of functions, ranging from control of the WNT signal transduction pathway, to functions in cell adhesion, migration, apoptosis and chromosomal segregation at mitosis (4) . Each of these roles is potentially linked with cancer development. However, the main tumour-suppressing function of APC resides in its role in the Wnt signal transduction pathway. This pathway induces the nuclear translocation of b-catenin and has a key role in cell-fate determination (2) . b-Catenin is found in a membrane-bound pool where it provides the essential link between E-cadherin and a-catenin in the adherens junctions (thus enhancing cell adhesion) and a more soluble pool that shuttles between cytoplasm and nucleus (thus transducing the canonical Wnt signal) (1, 5) . Cytoplasmic APC binds to and downregulates b-catenin, thereby preventing its nuclear activity. Tight regulation of Wnt/b-catenin signalling is essential, as uncontrolled nuclear accumulation of b-catenin can cause developmental defects and tumourigenesis in the adult organism (3) . In humans, most APC mutations causing colorectal tumours are inactivating mutations resulting in loss of functional APC protein and nuclear accumulation of b-catenin.
To study the role of APC in development and tumourigenesis, many inactivating mutant alleles of the mouse Apc gene have been generated. Several of these mutant alleles demonstrated gastrointestinal tumourigenesis in the heterozygous state, thereby mimicking to a certain extent the tumour phenotype of FAP patients (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) . However, mice with these constitutional Apc mutations developed mainly tumours in the small intestine. They succumbed to these tumours at a rather young age, thereby preventing studies on the long-term effect of loss of the wild-type Apc function in other tissues. Moreover, nearly all homozygous Apc-mutant mouse models were embryonic lethal.
To direct the development of intestinal tumours more specifically to the large intestine and to circumvent embryonic lethality associated with homozygosity, conditional Apc-mutant alleles have been created using the Cre/loxP conditional gene targeting system (16) . Indeed, mice homozygous for the Apc 580S allele, with loxP sites flanking exon 14, developed colorectal adenomas upon local infection with a Cre recombinase-encoding adenovirus (17) . However, Apc 580S/580S mice showed strongly reduced Apc expression ($30% of wild-type RNA expression) in the intestinal tract, indicating that the loxP sites and/or the positive selection cassette had an adverse effect on the expression level of the Apc gene. Inactivation of the Apc 580S allele by Cre expression preferentially in the large intestinal epithelium resulted in a shift of the distribution of the tumours to this part of the intestine. However, the total number of intestinal tumours was low (18) . In a second conditional Apc-mutant allele, Apc 2lox14 , again with exon 14 flanked by loxP sites, the selection cassette had been removed by Cre-mediated recombination (12) . Early studies using mice homozygous for these conditional Apc-mutant alleles and with an inducible Cre transgene showed that conditional deletion of Apc within the intestinal epithelium leads to a 'crypt progenitor cell-like' phenotype, with intestinal enterocytes showing proliferation, perturbed differentiation and migration (19, 20) .
We report here the construction and characterization of a new conditional Apc-mutant allele, Apc 15lox , with loxP sites flanking exon 15 and its germ line and distal intestine-specific knockout by Cre-mediated deletion of this exon.
Materials and methods

Targeting
The targeting construct was generated in two steps (Figure 1a ). First, a 10.3 kb SphI-SacI fragment, containing the 3#part of exon 15 and 3 kb of the 3# flanking region, was derived from a 129/J mouse genomic cosmid library and subcloned into the pBluescript vector. Next, a loxP-flanked PGKtk/PGKneo cassette was introduced into the ApaI site $350 bp downstream of the Apc polyadenylation signal. Both selectable markers were subsequently removed by introducing this vector into a bacterial strain, expressing Cre recombinase (kindly provided by F.Stewart, University of Technology, Dresden, Germany), leaving behind a single loxP site. For the second step, an 11.6 kb EcoRI fragment containing exons 11-14 and the 5# region of exon 15 was cloned into the pGEM7 vector. A loxP-flanked PGKneo cassette was cloned into the BglII site of intron 14. Subsequently, both vectors were combined to generate a 22.5 kb targeting vector which was linearized at the KpnI site before electroporation.
Electroporation and G418 selection of IB10 embryonic stem (ES) cells was carried out as described before (21) . Southern blot analysis of BamH1-digested DNA from 350 selected ES cell clones with a 3# external probe (1.1 kb SphIApaI genomic Apc fragment) showed in 20 clones a 5.7 kb band, indicative of a correctly recombined fragment (Figure 1a and b) . Sixteen of these 20 ES cell clones showed correct recombination at the 5# end of the targeting construct (12.0 kb band) as determined by Southern blot analysis of KpnI/SalI-digested Abbreviations: aa, amino acid; APC, adenomatous polyposis coli; ES, embryonic stem; FAP, familial adenomatous polyposis; IP, immunoprecipitation; PBS, phosphate-buffered saline; PCR, polymerase chain reaction. ES cells have previously been described (22) .
Immunoprecipitation and immunoblotting
Immunoprecipitation (IP) and western blot analysis of Apc were essentially performed as described (21) . For detection of Apc protein by IP, $2 Â 10 7 ES cells were rinsed twice in phosphate-buffered saline (PBS) and lysed for 15 min on ice in 800 ll of Triton X-100 IP buffer (30 mM Tris-HCl pH 7.4, 250 mM NaCl, 0.1% Triton X-100, 5 mM ethylenediaminetetraacetic acid, 50 mM NaF, 0.1 mM sodium vanadate and a cocktail of protease inhibitors (Complete Protease Inhibitor Cocktail tablets, Roche Diagnostics GmbH, Mannheim, Germany). To 400 ll of cleared lysate, obtained after centrifugation for 10 min at 11 000g, a preformed complex of AFPN rabbit polyclonal antibody (21) and protein A-Sepharose beads (Pharmacia, Roosendaal, The Netherlands) was added. After incubation at 4°C for 1 h under continuous mixing, the beads were washed 3-4 times with 1 ml of IP buffer. After the final wash, the pellet was resuspended in 50 ll of Laemmli sample buffer (120 mM Tris-HCl pH 6.8, 20% glycerol, 200 mM dithiothreitol, 4% sodium dodecyl sulphate and 0.02% bromophenol blue) and heated at 70°C for 10 min. Total lysates were obtained by washing the culture plates twice with PBS, followed by direct lysis on the plates using Laemmli sample buffer and heating at 70°C for 10 min.
For detection of Apc protein by western blot analysis, lysates were resolved on 8% sodium dodecyl sulphate-polyacrylamide gels and transferred onto polyvinylidene difluoride membranes (Immobilon-P, Millipore Corporation, Billerica, MA) by overnight electroblotting at 80 mA constant current at 4°C in 50 mM Tris-HCl pH 8.3, 384 mM glycine and 0.01% sodium dodecyl sulphate. Following transfer, the membranes were blocked with 5% nonfat dry milk in TBST (10 mM Tris-HCl pH 8.0, 150 mM NaCl and 0.05% Tween 20) for at least 1 h. After incubation for 1 h with primary Apc mouse monoclonal antibody Ab-1 (Calbiochem, Merck, Darmstadt, Germany) at a dilution of 1:100, the blot was washed 2-3 times with TBST and subsequently incubated with horseradish peroxidase-conjugated secondary antibodies for 1 h. The peroxidase was visualized by enhanced chemiluminescence.
Mice
All experiments on mice were performed in accordance with institutional and national guidelines and regulations. Mice were housed under conventional conditions. Germ line chimeras were generated by injection of 12-15 Apc 15lox/þ ES cells into C57Bl/6 blastocysts and crossed with C57Bl/6 mice to produce outbred heterozygous offspring. Apc 15lox/15lox mice were bred with homozygous EIIaCre mice (kind gift of H.Westphal, National Institutes of Health, Bethesda, MD) to generate EIIaCre;Apc 15lox/þ offspring. These double heterozygous mice were backcrossed to C57Bl/6 mice to generate Apc D15/þ progeny, which were maintained in a C57Bl/6 genetic background. Heterozygous FabplCre mice [Tg-Fabpl 4x at -132
Cre, kind gift of J.Gordon (Washington University School of Medicine, St Louis, MO) via National Cancer Institute-Frederick (23)] were bred with Apc 15lox/15lox mice to generate FabplCre;Apc 15lox/þ progeny.
Genotyping
The genotypes of all offspring were analysed by PCR on tail-tip DNA. The Apc þ and Apc 15lox alleles were detected in a single reaction with a combination of two forward primers, Apc-Lox3FW2 (5#-TAGGCACTGGACATAAGGGC-3#) and Apc-LoxNotBW3 (5#-CTTCGAGGGACCTAATAAC-3#), and one reverse primer, Apc-Lox3R2 (5#-GTAACTGTCAAGAATCAATGG-3#), yielding a 87 bp wild-type product (Apc-Lox3FW2/Apc-Lox3R2) and a 243 bp loxP product (Apc-LoxNotBW3/Apc-Lox3R2), respectively, plus under optimal conditions an extra 352 bp loxP product (Apc-Lox3FW2/Apc-Lox3R2). The Apc D15 allele was detected with primers Apc-plseq5#B (5#-GCAGGAATTCGATAT-CAAGC-3#) and Apc-Lox3R2 yielding a 259 bp product. The Apc þ and Apc
1638N
alleles were detected in a single reaction with one forward primer, Apc-A3 (5#-CTAGCCCAGACTGCTTCAAAAT-3#), and two reverse primers, Apc-C2 (5#-GGAAAAGTTTATAGGTGTCCCTTCT-3#) and PN3 (5#-GCCAGCTCA-TTCCTCCACTC-3#), yielding a 178 bp and 347 bp product, respectively. The EIIaCre and FabplCre transgenes were assayed with the forward primer Cre-F (5#-ATGTCCAATTTACTGACCGTACAC-3#) and reverse primer Cre-R (5#-GCCGCATAACCAGTGAAACA-3#) yielding a 300 bp product.
Allelic imbalance analysis of Apc
Tumour DNA isolation and allelic imbalance analysis were performed as described before (24) . In a single PCR reaction, both the Apc þ and Apc D15 allele were amplified using four allele-specific primers as follows: Apc-Lox3FW2 and Apc-Lox3R2, yielding a product of 87 bp product diagnostic of the Apc þ allele and Apc-plseq5'lox (5#-CGATAAGCTTCGAGGGACCT-3#) and Apcplseq3'lox (5#-AAATAGGCGTATCACGAGGC-3#), yielding a product of 119 bp diagnostic of the Apc D15 allele.
Extent of Cre-mediated exon 15 deletion in the intestine PCR analysis of exon 15 deletion was performed using primers Apc-plseq5#B and Apc-Lox3R2 as described for the genotyping. Southern blot analysis of exon 15 deletion was performed according to standard procedures. Six micrograms of DNA were digested by SacI and hybridized with the 2.3 kb EcoRV-SacI genomic Apc fragment probe. In case of Cre-mediated recombination, a band of 6.0 kb was detected corresponding to the Apc D15 allele, besides the bands of 3.0 and 3.2 kb corresponding to the Apc þ and Apc 15lox alleles, respectively. Image quant analysis was used to quantify the relative intensity of the Apc D15 band of each DNA sample. To verify the efficacy of Cre-mediated recombination of the FabplCre mice in situ, these mice were bred with ROSA26-LacZ reporter mice (25) to generate bi-transgenic mice. The intestinal tract of the bi-transgenic mouse was opened along the cephalocaudal axis, flushed with PBS and spread out flat on filter paper. These whole mount preparations were fixed in fixative (1% formaldehyde, 0.2% glutaraldehyde, 2 mM MgCl 2 and 5 mM ethyleneglycol-bis (aminoethylether)-tetraacetic acid in PBS) at room temperature for 45 min, washed three times in PBS, equilibrated in wash buffer (0.1 M sodium phosphate buffer pH 7.8, 2 mM MgCl 2 , 0.01% deoxycholate and 0.02% NP40). Subsequently, the Escherichia coli b-galactosidase activity was detected by staining of the intestinal tissue in wash buffer containing 1 mg/ml 5-bromo-4-chloro-3-indolyl b-D-galactoside (X-Gal), 5 mM K 3 Fe(CN) 6 and 5 mM K 4 Fe(CN) 6 , until blue staining was clearly visible.
Histological and immunohistochemical analysis
Tissues were fixed in NotoxÒ (Earth Safe Industries, Bellemead, NJ) or 4% neutral buffered formalin, embedded in paraffin, sectioned at 5 lm and stained with haematoxylin and eosin, according to standard procedures. Immunohistochemical analysis for b-catenin and Ki-67 was performed as described in Koelink et al. (26) . Immunohistochemical analysis for c-Myc was performed as described in Sansom et al. (27) . Histopathological analysis of the tumours was performed following the recommendations reported in the consensus report on pathology of mouse models of intestinal cancer (28) .
Results
Conditional Apc 15lox/15lox mice are normal A conditional mutant allele of Apc, referred to as Apc 15lox , was generated by gene targeting in ES cells using the Cre/loxP system (Figure 1a and b) . Cre-mediated recombination leads to deletion of the loxP-flanked exon 15, resulting in the Apc D15 allele (Figure 1a) . This 6.6 kb deleted exon 15 represents the last exon of Apc and encodes all domains involved in regulation of Wnt/b-catenin signalling as well as the last 2.5 of 7 N-terminal Armadillo domains and the C-terminal domains that associate with the microtubular cytoskeleton (Figure 1c ). Since the polyadenylation site is also included in exon 15, the recombination was predicted to lead to a hypomorphic mutant allele, expressing an unstable messenger RNA and a truncated Apc protein in diminished amounts (29) . To analyse the expression of the mutant Apc protein, we performed western blot analysis of Apc D15/þ ES cells, carrying a heterozygous deletion of exon 15. As it can be seen in Figure 1d , we barely detected the predicted 74 kDa Apc D15 protein in total protein lysates, whereas the similar-sized 95 kDa Apc Min protein was easily detectable. Enrichment of the Apc protein by IP made the truncated protein more discernable. Based on quantification relative to the Apc Min protein, we estimated that expression of the Apc D15 protein was $5% of normal Apc þ protein.
After chimera formation and germ line transmission, Apc 15lox/þ mice were intercrossed to generate Apc 15lox/15lox mice. Twenty-five of the 100 offspring had the Apc 15lox/15lox genotype, which is according to the expected Mendelian ratio. These Apc 15lox/15lox mice were viable, healthy and fertile and developed no intestinal tumours over a 2 year period, suggesting that the introduction of loxP sites in the genomic regions flanking exon 15 did not hamper normal Apc expression. Kaplan-Meier analysis revealed no significant difference between the survival of Apc 15lox/15lox and Apc 15lox/þ mice (P 5 0.454, log-rank test) (Figure 1e) . A second control on the non-hypomorphic (8) . Apc 15lox/1638N offspring were born at the expected Mendelian ratio and succumbed at a comparable age to intestinal tumours as their control Apc 1638N/þ littermates (mean age of 13.1 and 11.1 months, respectively). Again, Kaplan-Meier analysis revealed no significant difference in survival between Apc 15lox/1638N and Apc 1638N/þ mice (P 5 0.408, log-rank test) (Figure 1e) . We therefore concluded that the insertion of the loxP sites into the Apc introns did not impair the function of Apc in these mice.
Germ line mutant Apc D15/þ mice develop small intestinal tumours
To determine the phenotypic consequences of Cre-mediated deletion of Apc exon 15, we generated germ line heterozygous knockout mice carrying the Apc D15 allele in all cells. To this aim, Apc 15lox/15lox mice were bred with 'deleter' EIIaCre mice with mosaic Cre expression in germ cells (30) . EIIaCre;Apc 15lox/þ progeny, with germ cells mosaic for the EIIaCre;Apc D15/þ genotype, were backcrossed to C57Bl/6 mice to generate progeny heterozygous for the Apc D15 allele and lacking the EIIaCre transgene. The age at death of these Apc D15/þ mice (n 5 33) inversely correlated with the backcross generation: on average 4.5 (N2) to 2.5 (N6) months of age (Figure 2a) . The main reason of death was intestinal obstruction. Macroscopic analysis of the Apc D15/þ mice (n 5 7) revealed an average of 185 intestinal tumours (Table I) , 1-2 cutaneous cysts, infrequently desmoid tumours and severe anaemia. Nearly all intestinal tumours were found in the small intestine (95.5%), and the size was predominately small (,2 mm). Within the small intestine, the majority of tumours were located in the ileum (77.1%), whereas the remaining tumours were seen in the jejunum (13.0%), duodenum (7.2%) and periampullar region (2.7%). A high number of polyp adenomas was seen (Figure 2b) , as well as a few adenocarcinomas. Macroscopically, most adenomas had either a polypoid shape or flat appearance. Microscopically, tumours consisted of columnar epithelial cells with elongated, hyperchromatic, crowded nuclei, with loss of the normal maturation gradient of the crypt.
DNAs of intestinal tumours of Apc D15/þ mice were isolated and screened for allelic imbalance of the Apc þ allele. We selectively amplified in a single PCR both the Apc þ and Apc D15 allele. Allelic imbalance analysis of eight tumour and two control samples is shown in Figure 2c . A significant loss of the Apc þ allele (normalized Apc D15 :Apc þ ratio !1.5) could be detected in seven of eight (88%) tumours.
Thus, Apc D15/þ mice, generated by Cre-mediated germ line conversion of the normal Apc 15lox allele into an Apc D15 allele, showed a severe Apc Min -like phenotype, characterized by a high multiplicity of tumours in the small intestine and early lethality.
Conditional FabplCre;Apc 15lox/þ mice develop large intestinal tumours
To direct Cre-mediated deletion of exon 15 more specifically to the large intestinal epithelium, we bred Apc 15lox/15lox mice with FabplCre transgenic mice (line Fabpl 4x at -132 Cre) (23) . The transgene in these mice expresses the Cre recombinase driven by the enhancer-promoter region of the rat liver fatty acid-binding protein gene Fabpl, with greatest expression occurring in the distal small intestinal, caecal and large intestinal epithelia (31) .
First, we investigated the efficiency of Cre-mediated deletion in total intestinal DNA of FabplCre;Apc 15lox/þ mice at 4 weeks of age (Figure 3a and b) . Based on a comparison of the relative intensity of the Apc D15 allele versus that of the Apc 15lox allele, we estimated that the deletion occurred in 30, 52 and 20% of the cells in distal ileum, colon and rectum, respectively, which is in accordance with previously published data (31) . Although these data most probably represented an underestimation of the true frequency due to dilution of the intestinal epithelial DNA with that of stromal cells lacking the exon 15 deletion, we concluded that exon 15 was deleted in a significant proportion of the Cre-expressing intestinal tract. At this early age, we observed no intestinal tumour development microscopically (data not shown). Cre recombination in these regions was heterogeneous, as determined by b-galactosidase staining of intestinal tissues of young adult FabplCre;ROSA26-LacZ reporter bi-transgenic mice (Figure 3c ). All FabplCre;Apc 15lox/þ mice developed intestinal tumours. Compared with Apc D15/þ mice, they succumbed later to these tumours, i.e. at a mean age of 7.6 versus 3.4 months (Figure 2a) . Moreover, the total number of tumours was lower in the conditional knockout mice: on average 41 intestinal tumours compared with 185 in the Apc D15/þ mice ( Table I ). The intestinal tumours developed predominantly in New conditional Apc colorectal mouse model the large intestine (63%), and to a larger size (!2 mm) compared with those of Apc D15/þ mice (,2 mm) (Table I, Figure 4e ). Macroscopically, the growth pattern was pedunculated (polypoid) or sessile. Microscopically, the tumours were mainly adenomas (82%), 65% of which were low-grade adenomas and 17% were high-grade adenomas (Figure 4a-d) . The remaining 18% of tumours were welldifferentiated adenocarcinomas (Figure 4e-f) . Ninety-one per cent of mice developed low-grade adenomas, 50% high-grade adenomas and 50% adenocarcinomas. Hyperplasia was very uncommon. The wellcircumscribed adenomas were mainly composed of tubular structures lined by dysplastic epithelium. The low-grade adenomas showed branching or elongation of crypts with some reduction of interglandular stroma. The high-grade adenomas were characterized by marked reduction of interglandular stroma and complex irregularity of glands, with cribriform (sieve-like) structures and back-to-back glands. Cytologic atypia was more pronounced. Numerous mitoses with abnormal mitotic figures were present. Immunohistochemistry for b-catenin showed widespread expression throughout the tumour epithelium (Figure 4b and f) . Since c-Myc is required for the majority of Wnt target gene activation following Apc loss (27) , we examined the expression of c-Myc in the tumours. Immunostaining clearly showed increased c-Myc expression in the tumour cells (Figure 4c) . Consistent with the driving role of c-Myc in proliferation, we observed increased Ki-67 immunostaining in these cells (Figure 4d ).
Discussion
APC mutations play a prominent role in the pathogenesis of colorectal adenomas and carcinomas in man. Germ line mutations of APC lead to colorectal polyposis, the hallmark of the hereditary syndrome FAP (1), and somatic mutations of APC are associated with the majority of sporadic colorectal tumours (2, 3) . To study the role of Apc in development and tumourigenesis, different mouse models carrying targeted germ line Apc mutations have been generated. However, the tumours in these mice mainly develop in the small intestine, instead of the large intestine.
To model human colorectal tumourigenesis more faithfully, new Apc-mutant mice with tumours developing preferentially in the large intestine are urgently needed. To create such a mouse model, we generated a new conditional Apc 15lox -mutant allele, with exon 15 flanked by loxP sites. Cre-induced deletion of exon 15 in Apc 15lox/þ ES cells resulted in synthesis of a mutant protein of $74 kDa (Figure 1d) . Deletion of exon 15 would prevent normal splicing at the donor splice site of exon 14, resulting in retention of intron 14 in the transcript and generation of an in-frame stop codon. This would result in the synthesis of a truncated protein of 667 amino acids (aa), including 650 aa of the normal Apc protein, which is in accordance with the observed molecular weight of the truncated protein. The strongly reduced expression of the Apc D15 protein ($5% of normal Apc þ protein) implicates that the Apc D15 allele is a hypomorphic mutant allele, comparable with the Apc 1638N allele that expresses the mutant protein at only 2% of the normal level (8, 22) .
The Apc 15lox/þ and Apc 15lox/15lox mice were viable and tumour free, whereas compound heterozygous Apc 15lox/1638N mice were viable and survived like Apc 1638N/þ mice (Figure 1e ). These data strongly suggest that the introduced loxP sites did not impair the normal function of Apc. Germ line Cre-mediated deletion of exon 15 resulted in Apc D15/þ mice with an intestinal tumour burden (mean number of 185 tumours per mouse) and distribution (95% small intestine and 5% large intestine) comparable with that of most other constitutional Cre transgenic mice express Cre in the distal small and large intestine. (Table I) (6, 7, (9) (10) (11) (12) (13) (14) (15) . A notable exception is the Apc 1638N/þ mouse, which develops only five to six tumours mainly in small intestine (8) . The Apc D15 protein lacks all Wnt pathwaydownregulating domains, whereas the Apc 1638N protein comprises several of the b-catenin-binding and -downregulating domains and one axin-binding domain. Although both are synthesized at a low level, apparently the presence of these domains in the Apc 1638N protein suffices to strongly reduce the tumour burden in Apc 1638N/þ mice compared with Apc D15/þ mice. We found loss of the wild-type Apc allele in most of the intestinal tumours of Apc D15/þ mice, which is in accordance with Knudson's two-hit model (Figure 2c) .
Compared with Apc D15/þ mice generated by germ line Cremediated deletion of exon 15, conditional deletion specifically directed to the distal intestinal epithelium of FabplCre;Apc 15lox/þ mice resulted in a significantly longer survival and in the majority of tumours developing in the large intestine (Table I ). In addition, FabplCre;Apc 15lox/þ mice developed more tumours of larger size than Apc D15/þ mice and also adenocarcinomas at considerable frequency (18%), thereby mimicking human FAP-associated as well as sporadic colorectal tumour formation.
FabplCre;Apc 15lox/þ mice developed on average 4-fold more intestinal tumours, compared with a different conditional Apc-mutant mouse model, CDX2P-NLSCre;Apc 580S/þ , carrying a CDX2P-NLSCre transgene and the impaired exon 14-floxed Apc 580S allele (18) . Expression of the CDX2P-NLSCre transgene in the intestine was shown to be restricted to distal ileum, caecum and colorectum during late gestation and in adult tissues. Apart from the substantial difference in total tumour burden, the preferential colorectal accumulation of tumours, 63% in FabplCre;Apc 15lox/þ mice and 71% in CDX2P-NLSCre;Apc 580S/þ mice, and the frequency of adenocarcinomas (18% and 15-20%) in both models was remarkably similar. In addition, the median survival of each mouse model was comparable (7.6 months and 200 days). Loss of exon 14 would result in a shift of the reading frame and synthesis of a truncated protein of 605 aa, of which the first 580 aa correspond to the normal Apc protein (17) . A mutant Apc product with the predicted size of 70 kDa has been found in brain lysates of Apc 580D/þ mice carrying a constitutional deletion of exon 14 of Apc and indirect evidence suggests that this protein is synthesised in low amounts (14, 17) . If so, in both mouse models a low level of truncated Apc protein of comparable length is expressed (650 aa in FabplCre;Apc 15lox/þ mice and 580 aa in CDX2P-NLSCre;Apc 580S/þ mice). The 4-fold difference in tumour burden between the two models remains to be explained. Among others, it might be caused by differences in the promoters driving the Cre transgene expression (promoters of the rat liver fatty acid binding protein (Fabpl) gene and the human CDX2 homeobox gene) or by differences in exogenous factors, such as unidentified environmental parameters in which the mice were raised. Both promoters are known to differ in their extraintestinal activity. Besides the specific Cre expression of the Fapbl enhancer-promoter in the epithelial cells, including the stem cells, of the distal small intestine, caecum and large intestine, only one extraintestinal site of Cre expression has been detected: all layers of the urothelium, from the renal calyces to the ureters and bladder (31) . In contrast, although the CDX2 promoter and upstream flanking elements show restricted Cre expression in the distal small intestine, caecum and colon during late gestation and in adult tissues, they lead to broad Cre expression and function in the caudal half of mice during early development (18) . This may limit the use of this CDX2P-NLSCre transgene, especially if other loxP alleles are introduced into Apc-floxed backgrounds. More recently, the same authors reported an interesting approach to generate a mosaic Apc mutant genotype in the intestinal tract using a functionally inactive CDX2P9.5-G22Cre recombinase transgene with a long mononucleotide tract (32) . Stochastic activation of the Cre transgene by spontaneous frameshift mutation induced a severe colonic polyposis phenotype in CDX2P9.5-G22Cre;Apc 580S/580S mice, leading to the death of the animals within the first month of life, whereas heterozygous CDX2P9.5-G22Cre;Apc 580S/þ mice showed no overt signs of disease through 200 days of age (32) .
FabplCre;Apc 2lox14/þ mice, carrying the FabplCre transgene and another exon 14-floxed Apc allele, also developed large intestinal tumours upon Cre expression directed to this part of the intestine (33) . However, from the available data it could not be deduced whether these mice developed an increased number of large intestinal tumours compared with mice with a constitutional deletion of exon 14 (12) . New conditional Apc colorectal mouse model
In conclusion, we generated and characterized a new conditional Apc 15lox -mutant allele in the mouse, which can be converted by tissuespecific Cre expression into a hypomorphic mutant Apc D15 allele, encoding a truncated protein expressed in low amounts. The conditional Apc 15lox allele is well suited to study the lack of functional Apc in specific tissues in embryonic and adult stage. For instance, conditional inactivation of Apc in chondrocytes of Col2a1Cre;Apc 15lox/15lox embryos enabled us to demonstrate that Apc-mediated control of b-catenin is essential for both chondrogenic and osteogenic differentiation of skeletal precursors (34) . In addition, our conditional FabplCre;Apc 15lox/þ mouse model, because of its extended lifespan compared with most other Apc-mutant models, and the development of a significant number of adenomas and adenocarcinomas in the large intestine, is useful to study the genetic alterations associated with the adenomacarcinoma sequence in the mouse. Finally, the FabplCre;Apc 15lox/þ mouse is an attractive model for studies on prevention and treatment of sporadic colorectal cancer. Using this model, we have been able to show that 5-aminosalicylic acid (mesalazine) inhibits colitis-associated colorectal neoplasia but not sporadic colorectal neoplasia (26) . 
